75 related articles for article (PubMed ID: 38672281)
21. The AlkB Family: Potential Prognostic Biomarkers and Therapeutic Targets in Glioblastoma.
Feng S; Xu Z; Peng J; Zhang M
Front Oncol; 2022; 12():847821. PubMed ID: 35371987
[TBL] [Abstract][Full Text] [Related]
22. Construction and Comprehensive Analysis of a Stratification System Based on
Wang L; Zhang W; Yang T; He L; Liao Y; Lu J
Dis Markers; 2021; 2021():6144476. PubMed ID: 34840632
[TBL] [Abstract][Full Text] [Related]
23. RRM1 Expression as a Prognostic Biomarker for Unresectable or Recurrent Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin.
Chun JW; Lee B; Park WS; Han N; Hong EK; Park EY; Han SS; Park SJ; Kim TH; Lee WJ; Woo SM
J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682775
[TBL] [Abstract][Full Text] [Related]
24.
Liu S; Zhao W; Li X; Zhang L; Gao Y; Peng Q; Du C; Jiang N
Front Oncol; 2021; 11():713017. PubMed ID: 34595113
[TBL] [Abstract][Full Text] [Related]
25. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
Louis DN; Perry A; Wesseling P; Brat DJ; Cree IA; Figarella-Branger D; Hawkins C; Ng HK; Pfister SM; Reifenberger G; Soffietti R; von Deimling A; Ellison DW
Neuro Oncol; 2021 Aug; 23(8):1231-1251. PubMed ID: 34185076
[TBL] [Abstract][Full Text] [Related]
26. ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis.
Wu G; Yan Y; Cai Y; Peng B; Li J; Huang J; Xu Z; Zhou J
Front Cell Dev Biol; 2021; 9():633927. PubMed ID: 34150745
[TBL] [Abstract][Full Text] [Related]
27. Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma.
Xian J; Wang S; Jiang Y; Li L; Cai L; Chen P; Liu Y; Zeng X; Chen G; Ding C; Hoffman RM; Jia L; Zhao H; Zhang Y
Cancer Biol Med; 2021 Mar; 19(4):504-17. PubMed ID: 33733647
[TBL] [Abstract][Full Text] [Related]
28. Pan-cancer analyses demonstrate that ANKRD6 is associated with a poor prognosis and correlates with M2 macrophage infiltration in colon cancer.
Bai R; Wu D; Shi Z; Hu W; Li J; Chen Y; Ge W; Yuan Y; Zheng S
Chin J Cancer Res; 2021 Feb; 33(1):93-102. PubMed ID: 33707932
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome.
Esteve-Puig R; Climent F; Piñeyro D; Domingo-Domènech E; Davalos V; Encuentra M; Rea A; Espejo-Herrera N; Soler M; Lopez M; Ortiz-Barahona V; Tapia G; Navarro JT; Cid J; Farré L; Villanueva A; Casanova I; Mangues R; Santamarina-Ojeda P; Fernández AF; Fraga MF; Piris MA; Kol N; Avrahami C; Moshitch-Moshkovitz S; Rechavi G; Sureda A; Esteller M
Blood; 2021 Feb; 137(7):994-999. PubMed ID: 32915956
[No Abstract] [Full Text] [Related]
30. Management of glioblastoma: State of the art and future directions.
Tan AC; Ashley DM; López GY; Malinzak M; Friedman HS; Khasraw M
CA Cancer J Clin; 2020 Jul; 70(4):299-312. PubMed ID: 32478924
[TBL] [Abstract][Full Text] [Related]
31. Gross Total vs. Subtotal Resection on Survival Outcomes in Elderly Patients With High-Grade Glioma: A Systematic Review and Meta-Analysis.
Han Q; Liang H; Cheng P; Yang H; Zhao P
Front Oncol; 2020; 10():151. PubMed ID: 32257941
[No Abstract] [Full Text] [Related]
32. Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix.
Mendaza S; Fernández-Irigoyen J; Santamaría E; Zudaire T; Guarch R; Guerrero-Setas D; Vidal A; Santos-Salas J; Matias-Guiu X; Ausín K; Díaz de Cerio MJ; Martín-Sánchez E
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32204550
[TBL] [Abstract][Full Text] [Related]
33. Targeting Protein Neddylation for Cancer Therapy.
Zhou L; Jia L
Adv Exp Med Biol; 2020; 1217():297-315. PubMed ID: 31898235
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-1β drives NEDD8 nuclear-to-cytoplasmic translocation, fostering parkin activation via NEDD8 binding to the P-ubiquitin activating site.
Balasubramaniam M; Parcon PA; Bose C; Liu L; Jones RA; Farlow MR; Mrak RE; Barger SW; Griffin WST
J Neuroinflammation; 2019 Dec; 16(1):275. PubMed ID: 31882005
[TBL] [Abstract][Full Text] [Related]
35. Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity.
Vidyarthi A; Agnihotri T; Khan N; Singh S; Tewari MK; Radotra BD; Chatterjee D; Agrewala JN
Cancer Immunol Immunother; 2019 Dec; 68(12):1995-2004. PubMed ID: 31690954
[TBL] [Abstract][Full Text] [Related]
36. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.
Ostrom QT; Cioffi G; Gittleman H; Patil N; Waite K; Kruchko C; Barnholtz-Sloan JS
Neuro Oncol; 2019 Nov; 21(Suppl 5):v1-v100. PubMed ID: 31675094
[TBL] [Abstract][Full Text] [Related]
37. Transcripto-based network analysis reveals a model of gene activation in tongue squamous cell carcinomas.
Zeng H; Li H; Zhao Y; Chen L; Ma X
Head Neck; 2019 Dec; 41(12):4098-4110. PubMed ID: 31589000
[TBL] [Abstract][Full Text] [Related]
38. ALKBH overexpression in head and neck cancer: potential target for novel anticancer therapy.
Pilžys T; Marcinkowski M; Kukwa W; Garbicz D; Dylewska M; Ferenc K; Mieczkowski A; Kukwa A; Migacz E; Wołosz D; Mielecki D; Klungland A; Piwowarski J; Poznański J; Grzesiuk E
Sci Rep; 2019 Sep; 9(1):13249. PubMed ID: 31519943
[TBL] [Abstract][Full Text] [Related]
39. Neddylation: a novel modulator of the tumor microenvironment.
Zhou L; Jiang Y; Luo Q; Li L; Jia L
Mol Cancer; 2019 Apr; 18(1):77. PubMed ID: 30943988
[TBL] [Abstract][Full Text] [Related]
40. The role of RNA adenosine demethylases in the control of gene expression.
Rajecka V; Skalicky T; Vanacova S
Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):343-355. PubMed ID: 30550773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
